nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—KCNE1—ear—melanoma	0.0703	0.334	CbGeAlD
Indapamide—KCNQ1—ear—melanoma	0.0323	0.153	CbGeAlD
Indapamide—KCNE1—eye—melanoma	0.0185	0.0879	CbGeAlD
Indapamide—CYP3A4—Temozolomide—melanoma	0.012	0.576	CbGbCtD
Indapamide—KCNQ1—neck—melanoma	0.0114	0.0543	CbGeAlD
Indapamide—KCNE1—head—melanoma	0.0105	0.0499	CbGeAlD
Indapamide—KCNQ1—mammalian vulva—melanoma	0.00673	0.032	CbGeAlD
Indapamide—CYP3A4—Vemurafenib—melanoma	0.0066	0.316	CbGbCtD
Indapamide—CA2—hair follicle—melanoma	0.00623	0.0296	CbGeAlD
Indapamide—CA12—eye—melanoma	0.00605	0.0288	CbGeAlD
Indapamide—CA4—neck—melanoma	0.00504	0.024	CbGeAlD
Indapamide—KCNQ1—head—melanoma	0.00482	0.0229	CbGeAlD
Indapamide—CA5B—mammalian vulva—melanoma	0.00431	0.0205	CbGeAlD
Indapamide—CA2—neck—melanoma	0.00418	0.0199	CbGeAlD
Indapamide—CA12—head—melanoma	0.00344	0.0163	CbGeAlD
Indapamide—KCNQ1—lymph node—melanoma	0.00337	0.016	CbGeAlD
Indapamide—CA2—eye—melanoma	0.00311	0.0148	CbGeAlD
Indapamide—CA5B—head—melanoma	0.00308	0.0147	CbGeAlD
Indapamide—CA2—retina—melanoma	0.00308	0.0146	CbGeAlD
Indapamide—CA2—skin of body—melanoma	0.0027	0.0129	CbGeAlD
Indapamide—CA2—mammalian vulva—melanoma	0.00247	0.0117	CbGeAlD
Indapamide—CYP3A4—Docetaxel—melanoma	0.00226	0.108	CbGbCtD
Indapamide—CA5B—lymph node—melanoma	0.00216	0.0103	CbGeAlD
Indapamide—CA4—head—melanoma	0.00213	0.0101	CbGeAlD
Indapamide—CA2—head—melanoma	0.00176	0.00839	CbGeAlD
Indapamide—CA4—lymph node—melanoma	0.00149	0.00708	CbGeAlD
Indapamide—Pharyngitis—Temozolomide—melanoma	0.00139	0.00238	CcSEcCtD
Indapamide—Urinary tract disorder—Temozolomide—melanoma	0.00138	0.00237	CcSEcCtD
Indapamide—Oedema peripheral—Temozolomide—melanoma	0.00138	0.00236	CcSEcCtD
Indapamide—Pruritus—Vemurafenib—melanoma	0.00137	0.00236	CcSEcCtD
Indapamide—Lethargy—Docetaxel—melanoma	0.00137	0.00236	CcSEcCtD
Indapamide—Urethral disorder—Temozolomide—melanoma	0.00137	0.00235	CcSEcCtD
Indapamide—Hyponatraemia—Docetaxel—melanoma	0.00135	0.00232	CcSEcCtD
Indapamide—Visual impairment—Temozolomide—melanoma	0.00135	0.00231	CcSEcCtD
Indapamide—Erythema—Dactinomycin—melanoma	0.00134	0.00231	CcSEcCtD
Indapamide—Flushing—Carmustine—melanoma	0.00134	0.00231	CcSEcCtD
Indapamide—Ill-defined disorder—Bleomycin—melanoma	0.00134	0.0023	CcSEcCtD
Indapamide—Anaemia—Bleomycin—melanoma	0.00133	0.00229	CcSEcCtD
Indapamide—Diarrhoea—Vemurafenib—melanoma	0.00133	0.00228	CcSEcCtD
Indapamide—Migraine—Docetaxel—melanoma	0.00132	0.00227	CcSEcCtD
Indapamide—Erythema multiforme—Temozolomide—melanoma	0.00132	0.00227	CcSEcCtD
Indapamide—Tinnitus—Temozolomide—melanoma	0.0013	0.00224	CcSEcCtD
Indapamide—Malaise—Bleomycin—melanoma	0.0013	0.00223	CcSEcCtD
Indapamide—Cardiac disorder—Temozolomide—melanoma	0.0013	0.00223	CcSEcCtD
Indapamide—Flushing—Temozolomide—melanoma	0.0013	0.00223	CcSEcCtD
Indapamide—Arrhythmia—Carmustine—melanoma	0.00129	0.00222	CcSEcCtD
Indapamide—Leukopenia—Bleomycin—melanoma	0.00129	0.00222	CcSEcCtD
Indapamide—Dizziness—Vemurafenib—melanoma	0.00128	0.00221	CcSEcCtD
Indapamide—Ataxia—Docetaxel—melanoma	0.00126	0.00217	CcSEcCtD
Indapamide—Erythema—Carmustine—melanoma	0.00126	0.00216	CcSEcCtD
Indapamide—Malnutrition—Carmustine—melanoma	0.00126	0.00216	CcSEcCtD
Indapamide—Cough—Bleomycin—melanoma	0.00126	0.00216	CcSEcCtD
Indapamide—Dehydration—Docetaxel—melanoma	0.00125	0.00215	CcSEcCtD
Indapamide—Ill-defined disorder—Dactinomycin—melanoma	0.00125	0.00214	CcSEcCtD
Indapamide—Anaemia—Dactinomycin—melanoma	0.00124	0.00214	CcSEcCtD
Indapamide—Liver function test abnormal—Docetaxel—melanoma	0.00124	0.00213	CcSEcCtD
Indapamide—CA2—lymph node—melanoma	0.00124	0.00587	CbGeAlD
Indapamide—Vomiting—Vemurafenib—melanoma	0.00123	0.00212	CcSEcCtD
Indapamide—Chest pain—Bleomycin—melanoma	0.00123	0.00211	CcSEcCtD
Indapamide—Myalgia—Bleomycin—melanoma	0.00123	0.00211	CcSEcCtD
Indapamide—Orthostatic hypotension—Docetaxel—melanoma	0.00123	0.00211	CcSEcCtD
Indapamide—Abdominal pain upper—Docetaxel—melanoma	0.00123	0.00211	CcSEcCtD
Indapamide—Rash—Vemurafenib—melanoma	0.00122	0.0021	CcSEcCtD
Indapamide—Dermatitis—Vemurafenib—melanoma	0.00122	0.0021	CcSEcCtD
Indapamide—Back pain—Carmustine—melanoma	0.00122	0.00209	CcSEcCtD
Indapamide—Headache—Vemurafenib—melanoma	0.00122	0.00209	CcSEcCtD
Indapamide—Malnutrition—Temozolomide—melanoma	0.00122	0.00209	CcSEcCtD
Indapamide—Erythema—Temozolomide—melanoma	0.00122	0.00209	CcSEcCtD
Indapamide—Discomfort—Bleomycin—melanoma	0.00121	0.00208	CcSEcCtD
Indapamide—Malaise—Dactinomycin—melanoma	0.00121	0.00208	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00121	0.00208	CcSEcCtD
Indapamide—Cramp muscle—Docetaxel—melanoma	0.00121	0.00208	CcSEcCtD
Indapamide—Leukopenia—Dactinomycin—melanoma	0.0012	0.00207	CcSEcCtD
Indapamide—Nasopharyngitis—Docetaxel—melanoma	0.0012	0.00206	CcSEcCtD
Indapamide—Dysgeusia—Temozolomide—melanoma	0.00119	0.00205	CcSEcCtD
Indapamide—Vision blurred—Carmustine—melanoma	0.00119	0.00204	CcSEcCtD
Indapamide—Oedema—Bleomycin—melanoma	0.00118	0.00202	CcSEcCtD
Indapamide—Anaphylactic shock—Bleomycin—melanoma	0.00118	0.00202	CcSEcCtD
Indapamide—Back pain—Temozolomide—melanoma	0.00118	0.00202	CcSEcCtD
Indapamide—Infection—Bleomycin—melanoma	0.00117	0.00201	CcSEcCtD
Indapamide—Anaemia—Carmustine—melanoma	0.00116	0.002	CcSEcCtD
Indapamide—Dysphagia—Docetaxel—melanoma	0.00116	0.00199	CcSEcCtD
Indapamide—Agitation—Carmustine—melanoma	0.00116	0.00199	CcSEcCtD
Indapamide—Nausea—Vemurafenib—melanoma	0.00115	0.00198	CcSEcCtD
Indapamide—Thrombocytopenia—Bleomycin—melanoma	0.00115	0.00198	CcSEcCtD
Indapamide—Vision blurred—Temozolomide—melanoma	0.00115	0.00197	CcSEcCtD
Indapamide—Myalgia—Dactinomycin—melanoma	0.00114	0.00197	CcSEcCtD
Indapamide—Discomfort—Dactinomycin—melanoma	0.00113	0.00194	CcSEcCtD
Indapamide—Angina pectoris—Docetaxel—melanoma	0.00113	0.00194	CcSEcCtD
Indapamide—Ill-defined disorder—Temozolomide—melanoma	0.00113	0.00194	CcSEcCtD
Indapamide—Leukopenia—Carmustine—melanoma	0.00113	0.00194	CcSEcCtD
Indapamide—Anaemia—Temozolomide—melanoma	0.00112	0.00193	CcSEcCtD
Indapamide—Anorexia—Bleomycin—melanoma	0.00112	0.00193	CcSEcCtD
Indapamide—Agitation—Temozolomide—melanoma	0.00112	0.00192	CcSEcCtD
Indapamide—Angioedema—Temozolomide—melanoma	0.00111	0.00191	CcSEcCtD
Indapamide—Hypotension—Bleomycin—melanoma	0.0011	0.00189	CcSEcCtD
Indapamide—Oedema—Dactinomycin—melanoma	0.0011	0.00189	CcSEcCtD
Indapamide—Malaise—Temozolomide—melanoma	0.0011	0.00188	CcSEcCtD
Indapamide—Vertigo—Temozolomide—melanoma	0.00109	0.00188	CcSEcCtD
Indapamide—Infection—Dactinomycin—melanoma	0.00109	0.00187	CcSEcCtD
Indapamide—Leukopenia—Temozolomide—melanoma	0.00109	0.00187	CcSEcCtD
Indapamide—Palpitations—Temozolomide—melanoma	0.00107	0.00185	CcSEcCtD
Indapamide—Thrombocytopenia—Dactinomycin—melanoma	0.00107	0.00185	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00107	0.00184	CcSEcCtD
Indapamide—Myalgia—Carmustine—melanoma	0.00107	0.00184	CcSEcCtD
Indapamide—Chest pain—Carmustine—melanoma	0.00107	0.00184	CcSEcCtD
Indapamide—Anxiety—Carmustine—melanoma	0.00107	0.00183	CcSEcCtD
Indapamide—Cough—Temozolomide—melanoma	0.00106	0.00182	CcSEcCtD
Indapamide—Paraesthesia—Bleomycin—melanoma	0.00106	0.00182	CcSEcCtD
Indapamide—Weight decreased—Docetaxel—melanoma	0.00105	0.0018	CcSEcCtD
Indapamide—Dyspnoea—Bleomycin—melanoma	0.00105	0.0018	CcSEcCtD
Indapamide—Anorexia—Dactinomycin—melanoma	0.00105	0.0018	CcSEcCtD
Indapamide—Pneumonia—Docetaxel—melanoma	0.00104	0.00179	CcSEcCtD
Indapamide—Arthralgia—Temozolomide—melanoma	0.00104	0.00178	CcSEcCtD
Indapamide—Myalgia—Temozolomide—melanoma	0.00104	0.00178	CcSEcCtD
Indapamide—Anxiety—Temozolomide—melanoma	0.00103	0.00177	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00103	0.00177	CcSEcCtD
Indapamide—Oedema—Carmustine—melanoma	0.00103	0.00176	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00103	0.00176	CcSEcCtD
Indapamide—Discomfort—Temozolomide—melanoma	0.00102	0.00176	CcSEcCtD
Indapamide—Decreased appetite—Bleomycin—melanoma	0.00102	0.00176	CcSEcCtD
Indapamide—Infection—Carmustine—melanoma	0.00102	0.00175	CcSEcCtD
Indapamide—Renal failure—Docetaxel—melanoma	0.00102	0.00175	CcSEcCtD
Indapamide—Dry mouth—Temozolomide—melanoma	0.00101	0.00174	CcSEcCtD
Indapamide—Jaundice—Docetaxel—melanoma	0.00101	0.00173	CcSEcCtD
Indapamide—Stomatitis—Docetaxel—melanoma	0.00101	0.00173	CcSEcCtD
Indapamide—Pain—Bleomycin—melanoma	0.00101	0.00173	CcSEcCtD
Indapamide—Conjunctivitis—Docetaxel—melanoma	0.00101	0.00173	CcSEcCtD
Indapamide—Thrombocytopenia—Carmustine—melanoma	0.00101	0.00173	CcSEcCtD
Indapamide—Tachycardia—Carmustine—melanoma	0.001	0.00172	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.001	0.00172	CcSEcCtD
Indapamide—Anaphylactic shock—Temozolomide—melanoma	0.000993	0.00171	CcSEcCtD
Indapamide—Oedema—Temozolomide—melanoma	0.000993	0.00171	CcSEcCtD
Indapamide—Infection—Temozolomide—melanoma	0.000986	0.00169	CcSEcCtD
Indapamide—Anorexia—Carmustine—melanoma	0.000979	0.00168	CcSEcCtD
Indapamide—Hepatobiliary disease—Docetaxel—melanoma	0.000979	0.00168	CcSEcCtD
Indapamide—Nervous system disorder—Temozolomide—melanoma	0.000973	0.00167	CcSEcCtD
Indapamide—Thrombocytopenia—Temozolomide—melanoma	0.000972	0.00167	CcSEcCtD
Indapamide—Feeling abnormal—Bleomycin—melanoma	0.00097	0.00167	CcSEcCtD
Indapamide—Agranulocytosis—Docetaxel—melanoma	0.000966	0.00166	CcSEcCtD
Indapamide—Skin disorder—Temozolomide—melanoma	0.000964	0.00166	CcSEcCtD
Indapamide—Hypotension—Carmustine—melanoma	0.00096	0.00165	CcSEcCtD
Indapamide—Hyperhidrosis—Temozolomide—melanoma	0.00096	0.00165	CcSEcCtD
Indapamide—Decreased appetite—Dactinomycin—melanoma	0.000954	0.00164	CcSEcCtD
Indapamide—Fatigue—Dactinomycin—melanoma	0.000946	0.00163	CcSEcCtD
Indapamide—Anorexia—Temozolomide—melanoma	0.000946	0.00163	CcSEcCtD
Indapamide—Pain—Dactinomycin—melanoma	0.000938	0.00161	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Carmustine—melanoma	0.000936	0.00161	CcSEcCtD
Indapamide—Urticaria—Bleomycin—melanoma	0.000935	0.00161	CcSEcCtD
Indapamide—Rhinitis—Docetaxel—melanoma	0.000931	0.0016	CcSEcCtD
Indapamide—Body temperature increased—Bleomycin—melanoma	0.00093	0.0016	CcSEcCtD
Indapamide—Furosemide—ALB—melanoma	0.00093	0.408	CrCbGaD
Indapamide—Hepatitis—Docetaxel—melanoma	0.000929	0.0016	CcSEcCtD
Indapamide—Insomnia—Carmustine—melanoma	0.000929	0.0016	CcSEcCtD
Indapamide—Hypoaesthesia—Docetaxel—melanoma	0.000924	0.00159	CcSEcCtD
Indapamide—Paraesthesia—Carmustine—melanoma	0.000922	0.00158	CcSEcCtD
Indapamide—Pharyngitis—Docetaxel—melanoma	0.000922	0.00158	CcSEcCtD
Indapamide—Urinary tract disorder—Docetaxel—melanoma	0.000918	0.00158	CcSEcCtD
Indapamide—Dyspnoea—Carmustine—melanoma	0.000916	0.00157	CcSEcCtD
Indapamide—Oedema peripheral—Docetaxel—melanoma	0.000915	0.00157	CcSEcCtD
Indapamide—Somnolence—Carmustine—melanoma	0.000913	0.00157	CcSEcCtD
Indapamide—Urethral disorder—Docetaxel—melanoma	0.000911	0.00156	CcSEcCtD
Indapamide—Feeling abnormal—Dactinomycin—melanoma	0.000904	0.00155	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.000904	0.00155	CcSEcCtD
Indapamide—Insomnia—Temozolomide—melanoma	0.000898	0.00154	CcSEcCtD
Indapamide—Gastrointestinal pain—Dactinomycin—melanoma	0.000897	0.00154	CcSEcCtD
Indapamide—Visual impairment—Docetaxel—melanoma	0.000895	0.00154	CcSEcCtD
Indapamide—Decreased appetite—Carmustine—melanoma	0.000893	0.00153	CcSEcCtD
Indapamide—Paraesthesia—Temozolomide—melanoma	0.000891	0.00153	CcSEcCtD
Indapamide—Gastrointestinal disorder—Carmustine—melanoma	0.000887	0.00152	CcSEcCtD
Indapamide—Dyspnoea—Temozolomide—melanoma	0.000885	0.00152	CcSEcCtD
Indapamide—Somnolence—Temozolomide—melanoma	0.000882	0.00152	CcSEcCtD
Indapamide—Erythema multiforme—Docetaxel—melanoma	0.000879	0.00151	CcSEcCtD
Indapamide—Pain—Carmustine—melanoma	0.000878	0.00151	CcSEcCtD
Indapamide—Constipation—Carmustine—melanoma	0.000878	0.00151	CcSEcCtD
Indapamide—Dyspepsia—Temozolomide—melanoma	0.000874	0.0015	CcSEcCtD
Indapamide—Abdominal pain—Dactinomycin—melanoma	0.000868	0.00149	CcSEcCtD
Indapamide—Body temperature increased—Dactinomycin—melanoma	0.000868	0.00149	CcSEcCtD
Indapamide—Hypersensitivity—Bleomycin—melanoma	0.000867	0.00149	CcSEcCtD
Indapamide—Decreased appetite—Temozolomide—melanoma	0.000863	0.00148	CcSEcCtD
Indapamide—Cardiac disorder—Docetaxel—melanoma	0.000862	0.00148	CcSEcCtD
Indapamide—Flushing—Docetaxel—melanoma	0.000862	0.00148	CcSEcCtD
Indapamide—Gastrointestinal disorder—Temozolomide—melanoma	0.000857	0.00147	CcSEcCtD
Indapamide—Fatigue—Temozolomide—melanoma	0.000856	0.00147	CcSEcCtD
Indapamide—Pain—Temozolomide—melanoma	0.000849	0.00146	CcSEcCtD
Indapamide—Constipation—Temozolomide—melanoma	0.000849	0.00146	CcSEcCtD
Indapamide—Feeling abnormal—Carmustine—melanoma	0.000846	0.00145	CcSEcCtD
Indapamide—Asthenia—Bleomycin—melanoma	0.000844	0.00145	CcSEcCtD
Indapamide—Gastrointestinal pain—Carmustine—melanoma	0.00084	0.00144	CcSEcCtD
Indapamide—Pruritus—Bleomycin—melanoma	0.000833	0.00143	CcSEcCtD
Indapamide—Arrhythmia—Docetaxel—melanoma	0.00083	0.00143	CcSEcCtD
Indapamide—Feeling abnormal—Temozolomide—melanoma	0.000818	0.00141	CcSEcCtD
Indapamide—Abdominal pain—Carmustine—melanoma	0.000812	0.0014	CcSEcCtD
Indapamide—Body temperature increased—Carmustine—melanoma	0.000812	0.0014	CcSEcCtD
Indapamide—Gastrointestinal pain—Temozolomide—melanoma	0.000812	0.00139	CcSEcCtD
Indapamide—Malnutrition—Docetaxel—melanoma	0.000809	0.00139	CcSEcCtD
Indapamide—Erythema—Docetaxel—melanoma	0.000809	0.00139	CcSEcCtD
Indapamide—Hypersensitivity—Dactinomycin—melanoma	0.000809	0.00139	CcSEcCtD
Indapamide—Dysgeusia—Docetaxel—melanoma	0.000792	0.00136	CcSEcCtD
Indapamide—Bumetanide—PTGS2—melanoma	0.000791	0.347	CrCbGaD
Indapamide—Urticaria—Temozolomide—melanoma	0.000789	0.00135	CcSEcCtD
Indapamide—Asthenia—Dactinomycin—melanoma	0.000787	0.00135	CcSEcCtD
Indapamide—Body temperature increased—Temozolomide—melanoma	0.000785	0.00135	CcSEcCtD
Indapamide—Abdominal pain—Temozolomide—melanoma	0.000785	0.00135	CcSEcCtD
Indapamide—Back pain—Docetaxel—melanoma	0.000782	0.00134	CcSEcCtD
Indapamide—Muscle spasms—Docetaxel—melanoma	0.000778	0.00134	CcSEcCtD
Indapamide—Hypersensitivity—Carmustine—melanoma	0.000757	0.0013	CcSEcCtD
Indapamide—Diarrhoea—Dactinomycin—melanoma	0.000751	0.00129	CcSEcCtD
Indapamide—Vomiting—Bleomycin—melanoma	0.000748	0.00129	CcSEcCtD
Indapamide—Anaemia—Docetaxel—melanoma	0.000748	0.00128	CcSEcCtD
Indapamide—Rash—Bleomycin—melanoma	0.000742	0.00127	CcSEcCtD
Indapamide—Dermatitis—Bleomycin—melanoma	0.000741	0.00127	CcSEcCtD
Indapamide—Asthenia—Carmustine—melanoma	0.000737	0.00127	CcSEcCtD
Indapamide—Hypersensitivity—Temozolomide—melanoma	0.000731	0.00126	CcSEcCtD
Indapamide—Syncope—Docetaxel—melanoma	0.000725	0.00125	CcSEcCtD
Indapamide—Leukopenia—Docetaxel—melanoma	0.000724	0.00124	CcSEcCtD
Indapamide—Palpitations—Docetaxel—melanoma	0.000715	0.00123	CcSEcCtD
Indapamide—Asthenia—Temozolomide—melanoma	0.000712	0.00122	CcSEcCtD
Indapamide—Loss of consciousness—Docetaxel—melanoma	0.000711	0.00122	CcSEcCtD
Indapamide—Cough—Docetaxel—melanoma	0.000706	0.00121	CcSEcCtD
Indapamide—Diarrhoea—Carmustine—melanoma	0.000703	0.00121	CcSEcCtD
Indapamide—Pruritus—Temozolomide—melanoma	0.000702	0.00121	CcSEcCtD
Indapamide—Nausea—Bleomycin—melanoma	0.000699	0.0012	CcSEcCtD
Indapamide—Vomiting—Dactinomycin—melanoma	0.000698	0.0012	CcSEcCtD
Indapamide—Rash—Dactinomycin—melanoma	0.000692	0.00119	CcSEcCtD
Indapamide—Chest pain—Docetaxel—melanoma	0.000689	0.00118	CcSEcCtD
Indapamide—Myalgia—Docetaxel—melanoma	0.000689	0.00118	CcSEcCtD
Indapamide—Arthralgia—Docetaxel—melanoma	0.000689	0.00118	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000684	0.00118	CcSEcCtD
Indapamide—Dizziness—Carmustine—melanoma	0.000679	0.00117	CcSEcCtD
Indapamide—Diarrhoea—Temozolomide—melanoma	0.000679	0.00117	CcSEcCtD
Indapamide—Dry mouth—Docetaxel—melanoma	0.000673	0.00116	CcSEcCtD
Indapamide—Anaphylactic shock—Docetaxel—melanoma	0.00066	0.00113	CcSEcCtD
Indapamide—Oedema—Docetaxel—melanoma	0.00066	0.00113	CcSEcCtD
Indapamide—Dizziness—Temozolomide—melanoma	0.000656	0.00113	CcSEcCtD
Indapamide—Infection—Docetaxel—melanoma	0.000656	0.00113	CcSEcCtD
Indapamide—Vomiting—Carmustine—melanoma	0.000653	0.00112	CcSEcCtD
Indapamide—Nausea—Dactinomycin—melanoma	0.000652	0.00112	CcSEcCtD
Indapamide—Shock—Docetaxel—melanoma	0.000649	0.00112	CcSEcCtD
Indapamide—Rash—Carmustine—melanoma	0.000648	0.00111	CcSEcCtD
Indapamide—Nervous system disorder—Docetaxel—melanoma	0.000647	0.00111	CcSEcCtD
Indapamide—Dermatitis—Carmustine—melanoma	0.000647	0.00111	CcSEcCtD
Indapamide—Thrombocytopenia—Docetaxel—melanoma	0.000646	0.00111	CcSEcCtD
Indapamide—Tachycardia—Docetaxel—melanoma	0.000644	0.00111	CcSEcCtD
Indapamide—Headache—Carmustine—melanoma	0.000643	0.00111	CcSEcCtD
Indapamide—Skin disorder—Docetaxel—melanoma	0.000641	0.0011	CcSEcCtD
Indapamide—Vomiting—Temozolomide—melanoma	0.000631	0.00108	CcSEcCtD
Indapamide—Anorexia—Docetaxel—melanoma	0.000629	0.00108	CcSEcCtD
Indapamide—Rash—Temozolomide—melanoma	0.000626	0.00108	CcSEcCtD
Indapamide—Dermatitis—Temozolomide—melanoma	0.000625	0.00107	CcSEcCtD
Indapamide—Headache—Temozolomide—melanoma	0.000622	0.00107	CcSEcCtD
Indapamide—Hypotension—Docetaxel—melanoma	0.000617	0.00106	CcSEcCtD
Indapamide—Nausea—Carmustine—melanoma	0.00061	0.00105	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.000601	0.00103	CcSEcCtD
Indapamide—Insomnia—Docetaxel—melanoma	0.000597	0.00103	CcSEcCtD
Indapamide—Paraesthesia—Docetaxel—melanoma	0.000593	0.00102	CcSEcCtD
Indapamide—Nausea—Temozolomide—melanoma	0.00059	0.00101	CcSEcCtD
Indapamide—Dyspnoea—Docetaxel—melanoma	0.000589	0.00101	CcSEcCtD
Indapamide—Somnolence—Docetaxel—melanoma	0.000587	0.00101	CcSEcCtD
Indapamide—Dyspepsia—Docetaxel—melanoma	0.000581	0.000998	CcSEcCtD
Indapamide—Decreased appetite—Docetaxel—melanoma	0.000574	0.000986	CcSEcCtD
Indapamide—Gastrointestinal disorder—Docetaxel—melanoma	0.00057	0.000979	CcSEcCtD
Indapamide—Fatigue—Docetaxel—melanoma	0.000569	0.000978	CcSEcCtD
Indapamide—Pain—Docetaxel—melanoma	0.000564	0.00097	CcSEcCtD
Indapamide—Constipation—Docetaxel—melanoma	0.000564	0.00097	CcSEcCtD
Indapamide—Oxcarbazepine—ALB—melanoma	0.00056	0.246	CrCbGaD
Indapamide—Feeling abnormal—Docetaxel—melanoma	0.000544	0.000935	CcSEcCtD
Indapamide—Gastrointestinal pain—Docetaxel—melanoma	0.00054	0.000928	CcSEcCtD
Indapamide—Abdominal pain—Docetaxel—melanoma	0.000522	0.000897	CcSEcCtD
Indapamide—Body temperature increased—Docetaxel—melanoma	0.000522	0.000897	CcSEcCtD
Indapamide—Hypersensitivity—Docetaxel—melanoma	0.000486	0.000836	CcSEcCtD
Indapamide—Asthenia—Docetaxel—melanoma	0.000474	0.000814	CcSEcCtD
Indapamide—Pruritus—Docetaxel—melanoma	0.000467	0.000802	CcSEcCtD
Indapamide—Diarrhoea—Docetaxel—melanoma	0.000452	0.000776	CcSEcCtD
Indapamide—Dizziness—Docetaxel—melanoma	0.000437	0.00075	CcSEcCtD
Indapamide—Vomiting—Docetaxel—melanoma	0.00042	0.000721	CcSEcCtD
Indapamide—Rash—Docetaxel—melanoma	0.000416	0.000715	CcSEcCtD
Indapamide—Dermatitis—Docetaxel—melanoma	0.000416	0.000715	CcSEcCtD
Indapamide—Headache—Docetaxel—melanoma	0.000414	0.000711	CcSEcCtD
Indapamide—Nausea—Docetaxel—melanoma	0.000392	0.000674	CcSEcCtD
Indapamide—CA4—Metabolism—MTAP—melanoma	0.000262	0.00142	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP1B1—melanoma	0.000261	0.00141	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PLA2G6—melanoma	0.00026	0.00141	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIP4K2A—melanoma	0.000259	0.0014	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC6A11—melanoma	0.000259	0.0014	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—HIF1A—melanoma	0.000258	0.0014	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDK2—melanoma	0.000256	0.00139	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—MAPK1—melanoma	0.000254	0.00137	CbGpPWpGaD
Indapamide—CA2—Metabolism—MTAP—melanoma	0.000252	0.00136	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—melanoma	0.000251	0.00136	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—melanoma	0.000247	0.00134	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—ATM—melanoma	0.000243	0.00131	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PLA2G6—melanoma	0.000242	0.00131	CbGpPWpGaD
Indapamide—CA7—Metabolism—PLA2G6—melanoma	0.000242	0.00131	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDK4—melanoma	0.000242	0.00131	CbGpPWpGaD
Indapamide—CA4—Metabolism—PHGDH—melanoma	0.000234	0.00127	CbGpPWpGaD
Indapamide—CA4—Metabolism—LUM—melanoma	0.000234	0.00127	CbGpPWpGaD
Indapamide—CA5A—Metabolism—VCAN—melanoma	0.000233	0.00126	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ABCB1—melanoma	0.000233	0.00126	CbGpPWpGaD
Indapamide—CA9—Metabolism—PLCB4—melanoma	0.000232	0.00126	CbGpPWpGaD
Indapamide—CA4—Metabolism—HPSE—melanoma	0.000229	0.00124	CbGpPWpGaD
Indapamide—CA4—Metabolism—CUBN—melanoma	0.000225	0.00122	CbGpPWpGaD
Indapamide—CA12—Metabolism—PLA2G6—melanoma	0.000225	0.00122	CbGpPWpGaD
Indapamide—CA2—Metabolism—PHGDH—melanoma	0.000224	0.00122	CbGpPWpGaD
Indapamide—CA2—Metabolism—LUM—melanoma	0.000224	0.00122	CbGpPWpGaD
Indapamide—CA2—Metabolism—HPSE—melanoma	0.00022	0.00119	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC6A11—melanoma	0.000218	0.00118	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIP4K2A—melanoma	0.000218	0.00118	CbGpPWpGaD
Indapamide—CA7—Metabolism—VCAN—melanoma	0.000218	0.00118	CbGpPWpGaD
Indapamide—CA5B—Metabolism—VCAN—melanoma	0.000218	0.00118	CbGpPWpGaD
Indapamide—CA4—Metabolism—CSPG4—melanoma	0.000217	0.00118	CbGpPWpGaD
Indapamide—CA4—Metabolism—SDHD—melanoma	0.000217	0.00118	CbGpPWpGaD
Indapamide—CA4—Metabolism—BSG—melanoma	0.000217	0.00118	CbGpPWpGaD
Indapamide—CA2—Metabolism—CUBN—melanoma	0.000216	0.00117	CbGpPWpGaD
Indapamide—CA9—Metabolism—MTAP—melanoma	0.000212	0.00115	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—melanoma	0.000211	0.00114	CbGpPWpGaD
Indapamide—CA4—Metabolism—GPAM—melanoma	0.000211	0.00114	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—RB1—melanoma	0.00021	0.00114	CbGpPWpGaD
Indapamide—CA2—Metabolism—CSPG4—melanoma	0.000208	0.00113	CbGpPWpGaD
Indapamide—CA2—Metabolism—BSG—melanoma	0.000208	0.00113	CbGpPWpGaD
Indapamide—CA2—Metabolism—SDHD—melanoma	0.000208	0.00113	CbGpPWpGaD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—melanoma	0.000208	0.00113	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—AKR1B10—melanoma	0.000206	0.00112	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—HRAS—melanoma	0.000204	0.0011	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—melanoma	0.000203	0.0011	CbGpPWpGaD
Indapamide—CA2—Metabolism—GPAM—melanoma	0.000202	0.00109	CbGpPWpGaD
Indapamide—CA12—Metabolism—VCAN—melanoma	0.000202	0.00109	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP17A1—melanoma	0.000197	0.00107	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—melanoma	0.00019	0.00103	CbGpPWpGaD
Indapamide—CA9—Metabolism—PHGDH—melanoma	0.000189	0.00102	CbGpPWpGaD
Indapamide—CA9—Metabolism—LUM—melanoma	0.000189	0.00102	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GNA11—melanoma	0.000186	0.00101	CbGpPWpGaD
Indapamide—CA9—Metabolism—HPSE—melanoma	0.000185	0.001	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN2A—melanoma	0.000185	0.001	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP17A1—melanoma	0.000184	0.000995	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP17A1—melanoma	0.000184	0.000995	CbGpPWpGaD
Indapamide—CA9—Metabolism—CUBN—melanoma	0.000182	0.000986	CbGpPWpGaD
Indapamide—CA5A—Metabolism—FASN—melanoma	0.000182	0.000985	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MDM2—melanoma	0.000179	0.000971	CbGpPWpGaD
Indapamide—CA4—Metabolism—PLA2G6—melanoma	0.000179	0.00097	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SLC5A5—melanoma	0.000179	0.000969	CbGpPWpGaD
Indapamide—CA9—Metabolism—BSG—melanoma	0.000176	0.000952	CbGpPWpGaD
Indapamide—CA9—Metabolism—SDHD—melanoma	0.000176	0.000952	CbGpPWpGaD
Indapamide—CA9—Metabolism—CSPG4—melanoma	0.000176	0.000952	CbGpPWpGaD
Indapamide—CA7—Metabolism—GNA11—melanoma	0.000173	0.00094	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GNA11—melanoma	0.000173	0.00094	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GNAQ—melanoma	0.000173	0.000936	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CD44—melanoma	0.000173	0.000936	CbGpPWpGaD
Indapamide—CA2—Metabolism—PLA2G6—melanoma	0.000172	0.00093	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—melanoma	0.000171	0.000927	CbGpPWpGaD
Indapamide—CA9—Metabolism—GPAM—melanoma	0.00017	0.000922	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP17A1—melanoma	0.00017	0.000922	CbGpPWpGaD
Indapamide—CA5B—Metabolism—FASN—melanoma	0.00017	0.00092	CbGpPWpGaD
Indapamide—CA7—Metabolism—FASN—melanoma	0.00017	0.00092	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CXCL8—melanoma	0.000167	0.000907	CbGpPWpGaD
Indapamide—CA7—Metabolism—SLC5A5—melanoma	0.000167	0.000905	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC5A5—melanoma	0.000167	0.000905	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP1B1—melanoma	0.000166	0.000898	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN1B—melanoma	0.000164	0.000886	CbGpPWpGaD
Indapamide—CA7—Metabolism—GNAQ—melanoma	0.000161	0.000874	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GNAQ—melanoma	0.000161	0.000874	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CD44—melanoma	0.000161	0.000874	CbGpPWpGaD
Indapamide—CA7—Metabolism—CD44—melanoma	0.000161	0.000874	CbGpPWpGaD
Indapamide—CA4—Metabolism—VCAN—melanoma	0.000161	0.000872	CbGpPWpGaD
Indapamide—CA12—Metabolism—GNA11—melanoma	0.000161	0.000871	CbGpPWpGaD
Indapamide—CA12—Metabolism—FASN—melanoma	0.000157	0.000852	CbGpPWpGaD
Indapamide—CA12—Metabolism—SLC5A5—melanoma	0.000155	0.000838	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP1B1—melanoma	0.000155	0.000838	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP1B1—melanoma	0.000155	0.000838	CbGpPWpGaD
Indapamide—CA2—Metabolism—VCAN—melanoma	0.000154	0.000836	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—CDKN1A—melanoma	0.000151	0.000818	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—NFKB1—melanoma	0.00015	0.000812	CbGpPWpGaD
Indapamide—CA12—Metabolism—GNAQ—melanoma	0.000149	0.00081	CbGpPWpGaD
Indapamide—CA12—Metabolism—CD44—melanoma	0.000149	0.00081	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ALB—melanoma	0.000146	0.000789	CbGpPWpGaD
Indapamide—CA9—Metabolism—PLA2G6—melanoma	0.000145	0.000784	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP1B1—melanoma	0.000143	0.000776	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ABCB1—melanoma	0.000136	0.000739	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—melanoma	0.000136	0.000737	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP17A1—melanoma	0.000136	0.000735	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—STAT3—melanoma	0.000135	0.00073	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP17A1—melanoma	0.00013	0.000705	CbGpPWpGaD
Indapamide—CA9—Metabolism—VCAN—melanoma	0.00013	0.000704	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MAPK3—melanoma	0.000129	0.000697	CbGpPWpGaD
Indapamide—CA4—Metabolism—GNA11—melanoma	0.000128	0.000695	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ABCB1—melanoma	0.000127	0.00069	CbGpPWpGaD
Indapamide—CA7—Metabolism—ABCB1—melanoma	0.000127	0.00069	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PRKCA—melanoma	0.000126	0.00068	CbGpPWpGaD
Indapamide—CA4—Metabolism—FASN—melanoma	0.000125	0.00068	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ERCC2—melanoma	0.000124	0.000675	CbGpPWpGaD
Indapamide—CA4—Metabolism—SLC5A5—melanoma	0.000123	0.000669	CbGpPWpGaD
Indapamide—CA2—Metabolism—GNA11—melanoma	0.000123	0.000666	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MAPK1—melanoma	0.000122	0.000663	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—MDM2—melanoma	0.000122	0.000661	CbGpPWpGaD
Indapamide—CA2—Metabolism—FASN—melanoma	0.00012	0.000652	CbGpPWpGaD
Indapamide—CA4—Metabolism—CD44—melanoma	0.000119	0.000646	CbGpPWpGaD
Indapamide—CA4—Metabolism—GNAQ—melanoma	0.000119	0.000646	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC5A5—melanoma	0.000118	0.000641	CbGpPWpGaD
Indapamide—CA12—Metabolism—ABCB1—melanoma	0.000118	0.000639	CbGpPWpGaD
Indapamide—CA7—Metabolism—PRKCA—melanoma	0.000117	0.000635	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PRKCA—melanoma	0.000117	0.000635	CbGpPWpGaD
Indapamide—CA7—Metabolism—ERCC2—melanoma	0.000116	0.00063	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ERCC2—melanoma	0.000116	0.00063	CbGpPWpGaD
Indapamide—CA2—Metabolism—GNAQ—melanoma	0.000114	0.000619	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1B1—melanoma	0.000114	0.000619	CbGpPWpGaD
Indapamide—CA2—Metabolism—CD44—melanoma	0.000114	0.000619	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP17A1—melanoma	0.00011	0.000594	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1B1—melanoma	0.00011	0.000593	CbGpPWpGaD
Indapamide—CA12—Metabolism—PRKCA—melanoma	0.000109	0.000588	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP17A1—melanoma	0.000108	0.000585	CbGpPWpGaD
Indapamide—CA12—Metabolism—ERCC2—melanoma	0.000108	0.000583	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	0.000106	0.000577	CbGpPWpGaD
Indapamide—CA9—Metabolism—GNA11—melanoma	0.000104	0.000561	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—melanoma	0.000103	0.000557	CbGpPWpGaD
Indapamide—CA9—Metabolism—FASN—melanoma	0.000101	0.000549	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC5A5—melanoma	9.97e-05	0.00054	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CG—melanoma	9.83e-05	0.000533	CbGpPWpGaD
Indapamide—CA9—Metabolism—CD44—melanoma	9.63e-05	0.000522	CbGpPWpGaD
Indapamide—CA9—Metabolism—GNAQ—melanoma	9.63e-05	0.000522	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PPARG—melanoma	9.49e-05	0.000514	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—IL6—melanoma	9.41e-05	0.00051	CbGpPWpGaD
Indapamide—CA4—Metabolism—ABCB1—melanoma	9.41e-05	0.00051	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1B1—melanoma	9.23e-05	0.0005	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CG—melanoma	9.18e-05	0.000497	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CG—melanoma	9.18e-05	0.000497	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1B1—melanoma	9.09e-05	0.000492	CbGpPWpGaD
Indapamide—CA2—Metabolism—ABCB1—melanoma	9.02e-05	0.000489	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	8.96e-05	0.000486	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PPARG—melanoma	8.86e-05	0.00048	CbGpPWpGaD
Indapamide—CA7—Metabolism—PPARG—melanoma	8.86e-05	0.00048	CbGpPWpGaD
Indapamide—CA4—Metabolism—PRKCA—melanoma	8.66e-05	0.000469	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CD—melanoma	8.64e-05	0.000468	CbGpPWpGaD
Indapamide—CA4—Metabolism—ERCC2—melanoma	8.59e-05	0.000465	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ALB—melanoma	8.53e-05	0.000462	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CG—melanoma	8.5e-05	0.000461	CbGpPWpGaD
Indapamide—CA2—Metabolism—PRKCA—melanoma	8.3e-05	0.00045	CbGpPWpGaD
Indapamide—CA2—Metabolism—ERCC2—melanoma	8.23e-05	0.000446	CbGpPWpGaD
Indapamide—CA12—Metabolism—PPARG—melanoma	8.21e-05	0.000445	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CD—melanoma	8.07e-05	0.000437	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CD—melanoma	8.07e-05	0.000437	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ALB—melanoma	7.97e-05	0.000432	CbGpPWpGaD
Indapamide—CA7—Metabolism—ALB—melanoma	7.97e-05	0.000432	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCB1—melanoma	7.6e-05	0.000412	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CB—melanoma	7.53e-05	0.000408	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CD—melanoma	7.48e-05	0.000405	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—melanoma	7.46e-05	0.000404	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALB—melanoma	7.38e-05	0.0004	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CB—melanoma	7.03e-05	0.000381	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CB—melanoma	7.03e-05	0.000381	CbGpPWpGaD
Indapamide—CA9—Metabolism—PRKCA—melanoma	7e-05	0.000379	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—melanoma	6.97e-05	0.000378	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—melanoma	6.97e-05	0.000378	CbGpPWpGaD
Indapamide—CA9—Metabolism—ERCC2—melanoma	6.94e-05	0.000376	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CG—melanoma	6.78e-05	0.000367	CbGpPWpGaD
Indapamide—CA4—Metabolism—PPARG—melanoma	6.54e-05	0.000355	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CB—melanoma	6.52e-05	0.000353	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTEN—melanoma	6.51e-05	0.000353	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CG—melanoma	6.5e-05	0.000352	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—melanoma	6.46e-05	0.00035	CbGpPWpGaD
Indapamide—CA2—Metabolism—PPARG—melanoma	6.27e-05	0.00034	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTEN—melanoma	6.08e-05	0.000329	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTEN—melanoma	6.08e-05	0.000329	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ACER3—melanoma	6.06e-05	0.000328	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CD—melanoma	5.96e-05	0.000323	CbGpPWpGaD
Indapamide—CA4—Metabolism—ALB—melanoma	5.88e-05	0.000319	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CD—melanoma	5.72e-05	0.00031	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALB—melanoma	5.64e-05	0.000306	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTEN—melanoma	5.63e-05	0.000305	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—UGT2B10—melanoma	5.54e-05	0.0003	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CG—melanoma	5.48e-05	0.000297	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPARG—melanoma	5.29e-05	0.000287	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CB—melanoma	5.2e-05	0.000282	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HS3ST5—melanoma	5.15e-05	0.000279	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—melanoma	5.15e-05	0.000279	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CB—melanoma	4.98e-05	0.00027	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—melanoma	4.94e-05	0.000267	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CD—melanoma	4.82e-05	0.000261	CbGpPWpGaD
Indapamide—CA9—Metabolism—ALB—melanoma	4.76e-05	0.000258	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CA—melanoma	4.59e-05	0.000249	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTEN—melanoma	4.49e-05	0.000243	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTEN—melanoma	4.3e-05	0.000233	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CA—melanoma	4.29e-05	0.000232	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CA—melanoma	4.29e-05	0.000232	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CB—melanoma	4.2e-05	0.000228	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—melanoma	4.16e-05	0.000225	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CA—melanoma	3.97e-05	0.000215	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PLCB4—melanoma	3.9e-05	0.000212	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKT1—melanoma	3.75e-05	0.000203	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC6A11—melanoma	3.67e-05	0.000199	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIP4K2A—melanoma	3.67e-05	0.000199	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTEN—melanoma	3.63e-05	0.000197	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MTAP—melanoma	3.57e-05	0.000193	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKT1—melanoma	3.5e-05	0.00019	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKT1—melanoma	3.5e-05	0.00019	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKT1—melanoma	3.24e-05	0.000176	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PHGDH—melanoma	3.18e-05	0.000172	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—LUM—melanoma	3.18e-05	0.000172	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CA—melanoma	3.17e-05	0.000172	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HPSE—melanoma	3.12e-05	0.000169	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CUBN—melanoma	3.06e-05	0.000166	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CA—melanoma	3.04e-05	0.000165	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SDHD—melanoma	2.96e-05	0.00016	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—BSG—melanoma	2.96e-05	0.00016	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CSPG4—melanoma	2.96e-05	0.00016	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPAM—melanoma	2.87e-05	0.000155	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKT1—melanoma	2.59e-05	0.00014	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CA—melanoma	2.56e-05	0.000139	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKT1—melanoma	2.48e-05	0.000134	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PLA2G6—melanoma	2.44e-05	0.000132	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—VCAN—melanoma	2.19e-05	0.000119	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKT1—melanoma	2.09e-05	0.000113	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP17A1—melanoma	1.85e-05	0.0001	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GNA11—melanoma	1.74e-05	9.45e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—FASN—melanoma	1.71e-05	9.25e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC5A5—melanoma	1.68e-05	9.09e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GNAQ—melanoma	1.62e-05	8.78e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CD44—melanoma	1.62e-05	8.78e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1B1—melanoma	1.55e-05	8.42e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCB1—melanoma	1.28e-05	6.93e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PRKCA—melanoma	1.18e-05	6.38e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ERCC2—melanoma	1.17e-05	6.33e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CG—melanoma	9.22e-06	5e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARG—melanoma	8.9e-06	4.82e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CD—melanoma	8.11e-06	4.39e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALB—melanoma	8.01e-06	4.34e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CB—melanoma	7.07e-06	3.83e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—melanoma	7e-06	3.8e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTEN—melanoma	6.11e-06	3.31e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CA—melanoma	4.31e-06	2.33e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKT1—melanoma	3.52e-06	1.91e-05	CbGpPWpGaD
